Search Results - Daniel Pohl
- Showing 1 - 9 results of 9
-
1
-
2
-
3
-
4
-
5
Multicentre, non-interventional study of the efficacy and tolerability of linaclotide in the treatment of irritable bowel syndrome with constipation in primary, secondary and terti... by Daniel Pohl, Michael Fried, Dominic Lawrance, Elmar Beck, Heinz F. Hammer
Published in BMJ Open (2019-12-01)Get full text
Article -
6
-
7
Clarithromycin-based Helicobacter pylori eradication therapy is not associated with higher treatment failure compared with non-clarithromycin-based regimens in a tertiary referral... by Tobias Braendli, Valeria Schindler, Dominique Laurent Braun, Fritz R. Murray, Juliane Marie Hente, Daniel Pohl
Published in Swiss Medical Weekly (2023-01-01)Get full text
Article -
8
Detection rate of colorectal cancer by routine colonoscopy is comparable in patients aged 45–49 and 50–54 years by Carla Ammann, Rina Maqkaj, Marcel Andre Schneider, Stefanie Josefine Hehl, Ralph Fritsch, Daniel Pohl, Gerhard Rogler, Christoph Gubler, Matthias Turina, Michael Scharl
Published in Swiss Medical Weekly (2024-07-01)Get full text
Article -
9
Linaclotide utilization and potential for off-label use and misuse in three European countries by Javier Cid-Ruzafa, Brian E. Lacy, Anna Schultze, Mai Duong, Yi Lu, Mireia Raluy-Callado, Robert Donaldson, Darren Weissman, Ainhoa Gómez-Lumbreras, Dan Ouchi, Maria Giner-Soriano, Rosa Morros, Ahunna Ukah, Daniel Pohl
Published in Therapeutic Advances in Gastroenterology (2022-06-01)Get full text
Article
